openPR Logo
Press release

North America and Europe Pharmaceutical Marijuana- Market Size and Forecast Analysis 2017-2021

03-06-2017 04:56 PM CET | Health & Medicine

Press release from: SA-BRC

North America and Europe Pharmaceutical Marijuana- Market Size

Marijuana has received great attention in the recent past due to debate over legalization. Although various researchers advocate importance of pharmaceutical marijuana market in treatment of pain, nausea, and various neurological disorders, authorities have restricted its use due to potential drug abuse. Currently 28 states in the U.S. have legalized use of marijuana for medical use. Other major economies with a growing and potential pharmaceutical marijuana market include Australia, Austria, Chile, Canada, Colombia, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal, Spain, Switzerland, and Belgium. Germany legalized medical marijuana usage in January 2017, however the policy is expected to implement in March 2017. Majority of the countries around the globe have not completely legalized marijuana, and have modified the rules and regulations to restrict sale, cultivation and usage to avoid drug abuse. Marijuana is still considered as a schedule 1 drug in the U.S. under the Controlled Substances Act. Relaxing regulations across several major crop producing regions such as South America and Asia has led to significant import-export opportunities for medical grade marijuana and its extracts thus providing impetus to the pharmaceutical marijuana market.

Report Sample@ http://www.sa-brc.com/North-America-and-Europe-Pharmaceutical-Marijuana-Market-Assessment--Forecast-2017-2021/up86

The pharmaceutical marijuana market is gradually gaining traction as pharmaceutical companies have targeted tetrahydrocannabinol (THC) the active compound in marijuana plant as a potential therapeutic drug candidate. Syndros, by Insys Therapeutics, Inc., a liquid formulation of Marinol (dronabinol) a soft gel capsule was approved for the treatment of patients experiencing chemotherapy-induced nausea and vomiting. Sativex by GW Pharmaceuticals is an oral spray approved for multiple sclerosis spasticity in more than 15 countries outside of U.S. The company had received Fast Track review for the drug from the U.S. FDA in 2014. Sativex is the only currently approved drug in pharmaceutical marijuana market with natural cannabis extract, while other approved drugs consist of synthetic active ingredient. Various other drugs in pipeline are expected to reach in the market in the future. Abbott Laboratories, and Indevus Pharmaceuticals, are currently conducting clinical trials for candidates based on cannabis derivatives. Regulatory approvals and refinement of policies in the near future would add more products and fuel the pharmaceutical marijuana market.

Click For TOC@ http://www.sa-brc.com/North-America-and-Europe-Pharmaceutical-Marijuana-Market-Assessment--Forecast-2017-2021/upcomingdetail86

Increased research funding and supportive government policies have been major drivers for pharmaceutical marijuana market in North America and Europe. Various research institutes are trying to discover novel properties of cannabis extracts in treating chronic diseases. According to research published by the California Pacific Medical Center in San Francisco compounds extracted from cannabis may hinder cancer cell growth by inhibiting Id-1 gene whose expression levels are high in breast cancer patients. THC has also shown to delay progression of Alzheimer's disease. These research initiatives would provide solid grounds for considering cannabis extracts as potential therapeutic alternative. Pharmaceutical marijuana market has immense potential to expand not only in North America and Europe by also in other parts of the globe wit high prevalence of diseases such as cancer, epilepsy, Alzheimer's disease, pain, depression, anxiety, and others.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America and Europe Pharmaceutical Marijuana- Market Size and Forecast Analysis 2017-2021 here

News-ID: 458202 • Views: 844

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Pharmaceutical

Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market